Personal care and home fragrance retailer Bath & Body Works (NYSE:BBWI) will be announcing earnings results tomorrow before the bell. Here's what you need to know.
Last quarter Bath and Body Works reported revenues of $1.56 billion, down 2.6% year on year, in line with analyst expectations. It was a decent quarter for the company, with an impressive beat of analysts' earnings estimates. The company also raised its full year 2023 EPS guidance.
Is Bath and Body Works buy or sell heading into the earnings? Find out by reading the original article on StockStory.
This quarter analysts are expecting Bath and Body Works's revenue to decline 1.8% year on year to $2.84 billion, improvement on the 4.6% year-over-year decrease in revenue the company had recorded in the same quarter last year. Adjusted earnings are expected to come in at $1.87 per share.
Majority of analysts covering the company have reconfirmed their estimates over the last thirty days, suggesting they are expecting the business to stay the course heading into the earnings. The company only missed Wall St's revenue estimates once over the last two years, and has on average exceeded top line expectations by 1.1%.
Looking at Bath and Body Works's peers in the specialty retail segment, only Sally Beauty (NYSE:SBH) has so far reported results, with revenues decreasing 2.7% year on year, and beating analyst estimates by 0.3%. The stock traded flat on the results.
Read the full analysis of Sally Beauty's results on StockStory. There has been positive sentiment among investors in the specialty retail segment, with the stocks up on average 8.5% over the last month. Bath and Body Works is up 8.6% during the same time, and is heading into the earnings with analyst price target of $46.9, compared to share price of $47.4.
